Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABOGRAFT trial of antibiotic-impregnated bone graft in hip arthroplasty
2024-510921-25-00Phase 2Authorised
- Sponsor
- Region Östergötland
- Start
- Mar 2022
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised trial of vancomycin, tobramycin and saline in periprosthetic joint infection (PJI) (2 arms), sponsored by Region Östergötland. Planned start Mar 2022; status: authorised.
02
Drugs
vancomycintobramycinsaline
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on 2024-510921-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510921-25-00.